BUZZ BEAT MEDIA

Luxury skincare brand 111Skin has secured a major investment from SKKY Partners, the private equity firm co-founded by Kim Kardashian and Jay Sammons. This “significant” minority stake signals SKKY’s growing interest in high-end beauty, aligning with its strategy of investing in culturally relevant and high-growth brands.

The deal will fuel 111Skin’s expansion, particularly in North America and Asia, as it continues to build on its reputation for premium, science-driven skincare solutions.

Founded in 2012 by plastic and reconstructive surgeon Dr. Yannis Alexandrides and his wife, Eva, 111Skin is known for its advanced formulations, many inspired by treatments from Dr. Alexandrides’ Harley Street clinic in London. The brand has garnered a strong following among celebrities and skincare enthusiasts, thanks to its high-performance products like the Black Diamond Cream and Repair Serum, which promise medical-grade results. With its roots in clinical innovation, 111Skin has carved a niche in the luxury beauty market, blending science with opulence.

The investment from SKKY Partners is expected to help 111Skin enhance its direct-to-consumer (DTC) business, strengthen relationships with retailers such as Nordstrom and Cos Bar, and expand its footprint in key international markets. While financial terms were not disclosed, industry insiders suggest that SKKY sees 111Skin’s strong customer loyalty and brand positioning as valuable assets. “Eva, Yannis, and the 111Skin team have created and nurtured a coveted brand with world-class products and a loyal customer base,” said SKKY’s Managing Director, David Brisske. “111Skin has a strong foundation and significant ongoing potential.”

North America remains the brand’s largest market, but the company has also seen strong demand in China and Thailand, where its reputation has grown through its clinic’s international clientele. This investment will allow 111Skin to scale its operations and deepen its presence in these key regions. “We have quite a bit of brand recognition there,” noted Dr. Alexandrides.

Despite the investment, 111Skin’s founders will retain majority ownership and continue leading the company alongside CEO Vanessa Goddevrind. This ensures that the brand’s core values and commitment to scientific innovation remain intact. “We are excited to join forces with visionary partners that will help us write the future success story of our brand,” said Dr. Alexandrides. “The SKKY team has tremendous experience working with growth-oriented brands and shares our drive for excellence.”

SKKY Partners, established in 2022, has focused on investing in consumer-driven brands that resonate with modern audiences. This marks its first major investment in the beauty sector, joining its portfolio alongside Truff, a luxury sauce and condiments brand. Kardashian’s involvement in SKKY has evolved, with her current title as a senior operating advisor rather than a managing director.

With 111Skin’s revenues reaching £20.3 million ($24.9 million) in 2023 and a nearly doubled overseas sales growth from the previous year, the brand is well-positioned for its next phase of expansion. The partnership with SKKY is set to drive even greater success, cementing 111Skin’s place in the luxury skincare landscape.

*Cover Photo/Thumbnail Photo from cosmeticsbusiness.com